OPMEDIC GROUP and LMS enter license agreement to offer CALM Shoulder Screen(TM) to mothers



    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
    DISSEMINATION IN THE UNITES STATES/

    MONTREAL, Jan. 10 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC GROUP")
(TSX: OMG), which operates a network of private clinics in the province of
Quebec and LMS Medical Systems ("LMS"), the developer of the CALM(R) clinical
information system and risk management software for obstetrics, are pleased to
announce that they entered into an agreement pursuant to which OPMEDIC GROUP,
through its division PROCREA Cliniques ("PROCREA") will offer the CALM
Shoulder Screen test to pregnant women.
    While LMS will continue to market its tools to the public sector
hospitals in Quebec, PROCREA will have the exclusive use of the CALM Shoulder
Screen in the Quebec private clinic sector. PROCREA will begin to offer this
test for a fee in the coming days.
    CALM Shoulder Screen is the only test available on the market to assess
the risk of injury from shoulder dystocia, an obstetrical complication
occurring when the baby's shoulder gets stuck behind the mother's pubic bone
during childbirth. Potential injuries to the baby include brachial plexus
impairment, brain damage and sometimes death.
    PROCREA will introduce the test to over 300 physicians involved in
childbirth across the province of Quebec. Any pregnant woman in the province
may consult her own physician who will do an initial assessment, referring
those women who have certain risk factors associated with shoulder dystocia to
one of PROCREA's clinics for a late ultrasound and evaluation using the CALM
Shoulder Screen. PROCREA will report the patient's risk score for persistent
injury from shoulder dystocia to her physician. The availability of the test
will enable physicians to help their patients choose the safest possible
delivery that will enable them to avoid injury to their baby.
    "PROCREA provides a variety of fertility treatments and testing services
to patients and also offers diagnostic laboratory work, pre-natal screening
and fetal ultrasounds. Such services enable the physicians to counsel their
patients to better understand the risks the patients may face and the options
they have to make the best decisions for their family," said Dr. Pierre
St-Michel, CEO of OPMEDIC GROUP. "Offering CALM Shoulder Screen is consistent
with OPMEDIC GROUP's commitment to have PROCREA remain at the forefront of
clinical developments in this regard and to use the latest screening
technologies available to prevent birth complications for mothers and
newborns."
    "We are delighted that PROCREA will be offering this test across Quebec",
comments Diane Côté, CEO of LMS. "Now all women can benefit from this cutting
edge test to help prevent injury to their newborn wherever they plan to give
birth."

    About OPMEDIC GROUP

    OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".

    About LMS

    LMS is a leader in the application of advanced mathematical modeling and
neural networks for medical use. The LMS CALM Suite for Obstetrics provides
physicians, nursing staff, risk managers and hospital administrators with
clinical information systems and risk management tools designed to improve
outcomes and patient care for mothers and their infants during childbirth.

    This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

    The Content of this press release has not been approved by nor
    submitted to the TSX which assumes no liability therefore.




For further information:

For further information: Paulo Bouça, Vice President Business
Development and Chief Operating Officer, (514) 345-8535, x 2254,
pbouca@opmedicgroup.com

Organization Profile

Opmedic Group Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890